CpG Island Methylator Phenotype Predicts Progression of Malignant Melanoma
- 27 February 2009
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 15 (5), 1801-1807
- https://doi.org/10.1158/1078-0432.ccr-08-1361
Abstract
Purpose: The CpG island methylator phenotype (CIMP) may be associated with development of malignancy through coordinated inactivation of tumor suppressor and tumor-related genes (TRG) and methylation of multiple noncoding, methylated-in-tumor (MINT) loci. These epigenetic changes create a distinct CIMP pattern that has been linked to recurrence and survival in gastrointestinal cancers. Because epigenetic inactivation of TRGs also has been shown in malignant melanoma, we hypothesized the existence of a clinically significant CIMP in cutaneous melanoma progression. Experimental Design: The methylation status of the CpG island promoter region of TRGs related to melanoma pathophysiology (WIF1, TFPI2, RASSF1A, RARβ2, SOCS1, and GATA4) and a panel of MINT loci (MINT1, MINT2, MINT3, MINT12, MINT17, MINT25, and MINT31) in primary and metastatic tumors of different clinical stages (n = 122) was assessed. Results: Here, we show an increase in hypermethylation of the TRGs WIF1, TFPI2, RASSF1A, and SOCS1 with advancing clinical tumor stage. Furthermore, we find a significant positive association between the methylation status of MINT17, MINT31, and TRGs. The methylation status of MINT31 is associated with disease outcome in stage III melanoma. Conclusions: These findings show the significance of a CIMP pattern that is associated with advancing clinical stage of malignant melanoma. Future prospective large-scale studies may determine if CIMP-positive primary melanomas are at high risk of metastasis or recurrence.Keywords
Other Versions
This publication has 23 references indexed in Scilit:
- The Role of Tissue Factor Pathway Inhibitor-2 in Cancer BiologySeminars in Thrombosis and Hemostasis, 2007
- Silencing of tissue factor pathway inhibitor-2 gene in malignant melanomasInternational Journal of Cancer, 2007
- Assessment of Methylation Events during Colorectal Tumor Progression by Absolute Quantitative Analysis of Methylated AllelesMolecular Cancer Research, 2007
- Wnt Inhibitory Factor-1 Gene Transfer Inhibits Melanoma Cell GrowthHuman Gene Therapy, 2007
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Wnt Antagonist Family Genes as Biomarkers for Diagnosis, Staging, and Prognosis of Renal Cell Carcinoma Using Tumor and Serum DNAClinical Cancer Research, 2006
- Predictive Utility of Circulating Methylated DNA in Serum of Melanoma Patients Receiving BiochemotherapyJournal of Clinical Oncology, 2005
- Synthesis of universal unmethylated control DNA by nested whole genome amplification with ϕ29 DNA polymeraseBiochemical and Biophysical Research Communications, 2005
- Hypermethylation of the GATA Genes in Lung CancerClinical Cancer Research, 2004
- GATA-4 and GATA-5 Transcription Factor Genes and Potential Downstream Antitumor Target Genes Are Epigenetically Silenced in Colorectal and Gastric CancerMolecular and Cellular Biology, 2003